Disparities in children’s mental health care could be addressed through expansion of school-based programs via passage of the Mental Health in Schools Act.
AMA J Ethics. 2016;18(12):1218-1224. doi:
10.1001/journalofethics.2016.18.12.pfor1-1612.
This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements.
Colonel Paul F. Pasquina, USA (Ret), MD, Antonio J. Carvalho, and Terrence Patrick Sheehan, MD
Health outcomes for people who have had amputations are affected not only by barriers to access, such as race, socioeconomic status and cost, but also by the type of facility where they receive treatment and rehabilitative services.
AMA J Ethics. 2015;17(6):535-546. doi:
10.1001/journalofethics.2015.17.6.stas1-1506
Levan Atanelov, MD, MS, Steven A. Stiens, MD, MS, and Mark A. Young, MD, MBA
Physical medicine and rehabilitation has developed into a medical specialty that aims to restore optimal patient function in multiple dimensions of life with an interdisciplinary approach to care delivery.
AMA J Ethics. 2015;17(6):568-574. doi:
10.1001/journalofethics.2015.17.6.mhst1-1506.
Framing discussions of ALS around the disease rather than the psychologically complex person with the disease focuses attention on symptoms and imagined outcomes rather than patients’ coping strategies and quality of life.
AMA J Ethics. 2015;17(6):530-534. doi:
10.1001/journalofethics.2015.17.6.nlit2-1506.
This month theme issue editor, Trahern Jones, a fourth-year student at Mayo Medical School in Rochester, Minnesota, spoke with Dr. Edward Laskowski about the use of performance-enhancing drugs and substances among athletes today.
Concerns about the deleterious effects of stress on the mind and body have led to the beginnings of a stress vaccine, an injection that will reduce these effects.
Conflicts between federal and state laws governing marijuana, lack of evidence about its efficacy as a treatment, and physicians' inability to predict or control dosage would all be aided by reclassification of the drug that would let clinical research go forward.
Laurel J. Lyckholm, MD and Arwa K. Aburizik, MD, MS
Decision-making capacity can be preserved in patients with mental illness and should be formally assessed in the context of their values and past decisions.
AMA J Ethics. 2017;19(5):444-453. doi:
10.1001/journalofethics.2017.19.5.ecas4-1705.
Is it ethical to create and advertise, either publicly or during office visits, package deals that offer patients an incentive to have procedures they are not already seeking and might not have considered?